Article
Association of CYP2D6 single-nucleotide polymorphism with response to ophthalmic timolol in primary open-angle Glaucoma--a pilot study.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics - 1 Oct 2010
Yuan Hongzhi, Yu Minbin, Yang Yangfan, Wu Kaili, Lin Xianchai, Li Jinrong
Abstract excerpt
OBJECTIVES: We aimed to investigate whether CYP2D6 polymorphisms were associated with the intraocular pressure (IOP)-lowering effect and systemic complications (especially bradycardia) of ophthalmic timolol. METHODS: One hundred twenty-three primary open-angle glaucoma subjects (123 eyes) were treated with 0.5% aqueous formulations of ophthalmic timolol. IOP and heart rate were measured before and after timolol...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
